These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9106649)

  • 21. Docetaxel induced cardiotoxicity.
    Shimoyama M; Murata Y; Sumi KI; Hamazoe R; Komuro I
    Heart; 2001 Aug; 86(2):219. PubMed ID: 11454849
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammation of actinic keratoses during paclitaxel chemotherapy.
    Ali FR; Yiu ZZ; Fitzgerald D
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26055606
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 24. Recall phenomena: another facet of the immunocompromised district.
    Ruocco V; Ruocco E; Brunetti G
    Int J Dermatol; 2013 Feb; 52(2):252-3. PubMed ID: 23347316
    [No Abstract]   [Full Text] [Related]  

  • 25. Thromboembolic events with paclitaxel.
    Chan AT; Yeo W; Leung WT; Johnson PJ
    Clin Oncol (R Coll Radiol); 1996; 8(2):133. PubMed ID: 8859617
    [No Abstract]   [Full Text] [Related]  

  • 26. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
    Camidge DR; Kunkler IH
    Clin Oncol (R Coll Radiol); 2000; 12(4):272-3. PubMed ID: 11005698
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune Complex-Mediated Proliferative Glomerulonephritis Induced by Paclitaxel Treatment.
    Siddiqui B; Greka A; Popovtzer M; Rennke HG; Jeselsohn R
    J Oncol Pract; 2016 Dec; 12(12):1272-1274. PubMed ID: 27845869
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertrophic osteoarthropathy associated with docetaxel treatment.
    Tas F; Aydiner A; Tenekeci N; Karadeniz A; Sakar B; Topuz E
    Clin Oncol (R Coll Radiol); 2001; 13(2):145-6. PubMed ID: 11373880
    [No Abstract]   [Full Text] [Related]  

  • 29. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel.
    Vaidya GN; Acevedo R
    Am J Emerg Med; 2015 Feb; 33(2):308.e1-2. PubMed ID: 25178848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations.
    Budman DR; Weiselberg L; O'Mara V
    J Natl Cancer Inst; 1997 Jan; 89(1):87-8. PubMed ID: 8978412
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 34. Subungal abcesses secondary to paclitaxel.
    Albares MP; Belinchón I; Pascual JC; Vergara G; Blanes M; Betlloch I
    Dermatol Online J; 2003 Aug; 9(3):16. PubMed ID: 12952763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel in early breast cancer: a viewpoint by David A. Cameron.
    Cameron DA
    Drugs; 2004; 64(16):1848-9. PubMed ID: 15301567
    [No Abstract]   [Full Text] [Related]  

  • 36. A paclitaxel-induced variant of hand-foot syndrome affecting dorsal surfaces.
    Zelman B; Lee K; Reserva J; Speiser J
    J Cutan Pathol; 2021 Oct; 48(10):1320-1323. PubMed ID: 33938036
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fulminant hepatocellular necrosis following administration of docetaxel].
    Tomassini E; Muhizi J; al Raheb K; Steinbach G; Bemer M; Platini C
    Presse Med; 2001 Apr; 30(13):634. PubMed ID: 11346902
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of cystic maculopathy during paclitaxel therapy].
    Ito S; Okuda M
    Nippon Ganka Gakkai Zasshi; 2010 Jan; 114(1):23-7. PubMed ID: 20112801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paclitaxel in therapy of breast carcinoma. Value and perspectives].
    Klaassen U; Seeber S
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():7-10. PubMed ID: 9082172
    [No Abstract]   [Full Text] [Related]  

  • 40. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.